Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-14-057292
Filing Date
2014-09-23
Accepted
2014-09-23 12:21:21
Documents
11
Period of Report
2014-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v389832_6-k.htm 6-K 47286
2 EXHIBIT 99.1 v389832_ex99-1.htm EX-99.1 4890
3 EXHIBIT 99.2 v389832_ex99-2.htm EX-99.2 42079
4 GRAPHIC ex1_001.jpg GRAPHIC 197839
5 GRAPHIC ex1_002.jpg GRAPHIC 290085
6 GRAPHIC ex1_003.jpg GRAPHIC 15000
7 GRAPHIC ex1_004.jpg GRAPHIC 363006
8 GRAPHIC ex1_005.jpg GRAPHIC 308321
9 GRAPHIC ex1_006.jpg GRAPHIC 250718
10 GRAPHIC ex1_007.jpg GRAPHIC 212621
11 GRAPHIC image_001.jpg GRAPHIC 2946
  Complete submission text file 0001144204-14-057292.txt   2356666
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 141115542
SIC: 2834 Pharmaceutical Preparations